Sage G Ford

Mr. Sage G Ford

orcid

Research Focus & Metrics

Academic Career Length

2Years (2025-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
27 January 2025 in The Journal of Physiology
Verified
Journal Article
Open access
WTWen Tong
Wen Tong
Beth J. AllisonBeth J. Allison
Beth J. Allison
KBKirsty L. Brain
Kirsty L. Brain
POPatey Olga
Patey Olga
YNYouguo Niu
Youguo Niu
Dino GiussaniDino Giussani
Dino Giussani
The mechanisms that drive placental dysfunction in pregnancies complicated by hypoxia and fetal growth restriction remain poorly understood. Changes to mitochondrial respiration contribute to cellular dysfunction in conditions of hypoxia and have been implicated in the pathoaetiology of pregnancy complications, such as pre‐eclampsia. We used bespoke isobaric hypoxic chambers and a combination of functional, molecular and imaging techniques to study cellular metabolism and mitochondrial dynamics in sheep undergoing hypoxic pregnancy. We show that hypoxic pregnancy in sheep triggers a shift in capacity away from β‐oxidation and complex I‐mediated respiration, while maintaining total oxidative phosphorylation capacity. There are also complex‐specific changes to electron transport chain composition and a switch in mitochondrial dynamics towards fission. Hypoxic placentas show increased activation of the non‐canonical mitochondrial unfolded protein response pathway and enhanced insulin like growth factor 2 signalling. Combined, therefore, the data show that the hypoxic placenta undergoes significant metabolic and morphological adaptations to maintain cellular energy balance. Chronic hypoxia during pregnancy in sheep activated placental mitochondrial stress pathways, leading to alterations in mitochondrial respiration, mitochondrial energy metabolism and mitochondrial dynamics, as seen in the placenta of women with pre‐eclampsia. image Key points: Hypoxia shifts mitochondrial respiration away from β‐oxidation and complex I. Complex‐specific changes occur in the electron transport chain composition. Activation of the non‐canonical mitochondrial unfolded protein response pathway is heightened in hypoxic placentas. Enhanced insulin like growth factor 2 signalling is observed in hypoxic placentas. Hypoxic placentas undergo significant functional adaptations for energy balance.

22 February 2025 in Pharmaceutics
Verified
Journal Article
Open access
PDF file
MBMillicent Grace Alison Bennett
Millicent Grace Alison Bennett
AMAshley Meakin
Ashley Meakin
KBKimberley J. Botting-Lawford
Kimberley J. Botting-Lawford
YNYouguo Niu
Youguo Niu
SFSage G Ford
Sage G Ford
JMJanna Morrison
Janna Morrison
Background/Objectives: In pregnancy threatened by preterm birth, antenatal corticosteroids (ACS) are administered to accelerate fetal lung maturation. However, they have side effects, including the production of reactive oxygen species that can impact cytochrome P450 (CYP) activity. We hypothesised that antioxidants could protect a fetus treated with ACS during gestation and prevent the programming of altered hepatic CYP activity in the offspring. The primary outcome of our study was the impact of different maternal treatments on the activity of hepatic drug-metabolising enzymes in offspring. Methods: At 100 ± 1 days gestational age (dGA, term = 147 dGA), 73 ewes were randomly allocated to the following: saline (5 mL IV daily 105–137 ± 2 dGA, n = 17), ACS (Dexamethasone (Dex); 12 mg IM at 115 and 116 dGA; n = 25), MitoQ (6 mg/kg MS010 IV, daily bolus 105–137 ± 2 dGA; n = 17) or Dex and MitoQ (Dex+MitoQ; n = 14). CYP activity and protein abundance were assessed using functional assays and Western blot. Results: Dex decreased the hepatic activity of fetal CYP3A (−56%, PDex = 0.0322), and 9 mo lamb CYP1A2 (−22%, PDex = 0.0003), CYP2B6 (−36%, PDex = 0.0234), CYP2C8 (−34%, PDex = 0.0493) and CYP2E1 (−57%, PDex = 0.0009). For all, except CYP1A2, activity returned to control levels with Dex+MitoQ in 9 mo lambs. In 9 mo lambs, MitoQ alone increased activity of CYP2B6 (+16%, PMitoQ = 0.0011) and CYP3A (midazolam, +25%, PMitoQ = 0.0162) and increased CAT expression (PMitoQ = 0.0171). Dex+MitoQ increased CYP3A4/5 activity (testosterone, +65%, PIntx < 0.0003), decreased CYP1A2 activity (−14%, PIntx = 0.0036) and decreased mitochondrial abundance (PIntx = 0.0051). All treatments decreased fetal hepatic DRP1, a regulator of mitochondrial fission (PDex = 0.0055, PMitoQ = 0.0006 and PIntx = 0.0034). Conclusions: Antenatal Dex reduced activity of only one CYP in the fetus but programmed the reduced activity of several hepatic CYPs in young adult offspring, and this effect was ameliorated by combination with MitoQ.

22 May 2026 in The Journal of Physiology
Verified
Journal Article
Open access
RCRachael C. Crew
Rachael C. Crew
ACAnna L. K. Cochrane
Anna L. K. Cochrane
YNYouguo Niu
Youguo Niu
SFSage G Ford
Sage G Ford
CCClement L. R. Cahen
Clement L. R. Cahen
Dino GiussaniDino Giussani
Dino Giussani
Obesity during pregnancy is at pandemic proportions and predisposes women to pre‐ and postnatal cardiovascular dysfunction. The mechanisms underlying this maternal cardiovascular vulnerability remain unclear, partly due to a lack of translatable models capable of longitudinal in vivo cardiovascular monitoring. Here, we characterize a novel ovine model of maternal diet‐induced obesity during pregnancy. Ewes were fed a control (CON) or obesogenic (OB; ad libitum concentrates) diet for 60 days pre‐pregnancy and throughout gestation. Pregnant ewes were surgically instrumented with vascular catheters and Transonic flow probes using the wireless CamDAS system, which measured maternal cardiovascular function near term in free‐moving ewes. Uterine artery vasoreactivity was assessed ex vivo by in vitro wire myography. OB ewes entered pregnancy 30% heavier than controls ( P < 0.003) and were hyperglycaemic, hyperinsulinaemic and hyperlipidaemic during pregnancy, relative to CON ewes (all P < 0.05). OB ewes had elevated haematocrit and haemoglobin across pregnancy, and were hypertensive near term, with an increase in basal femoral artery blood flow, and elevated peripheral oxygen and glucose delivery (all P < 0.05). OB mothers carrying a female fetus showed increased uterine artery vascular resistance in vivo ( P < 0.005) and reduced smooth muscle‐dependent vasorelaxation ex vivo ( P < 0.05) relative to CON. Conversely, OB mothers carrying a male fetus showed greater NO‐independent mechanisms mediating the uterine vasodilator response to methacholine ex vivo ( P < 0.001). Collectively, this study characterizes a robust model of maternal obesity during pregnancy that offers clinical translational potential and highlights fetal sex‐specific changes to uterine artery function. image Key points: Obesity during pregnancy is increasingly common and predisposes women to cardiovascular dysfunction during pregnancy and long after birth, but the specific mechanisms underlying this remain unclear. We developed a novel ovine model of diet‐induced obesity during pregnancy that displays maternal hypertension, elevated haemoglobin, metabolic dysfunction, and alterations in uterine and peripheral blood flow and nutrient delivery near term. Mothers with obesity carrying a female fetus had elevated uterine vascular resistance in vivo and reduced uterine artery smooth muscle‐dependent vasodilator reactivity ex vivo . Mothers with obesity carrying a male fetus showed no effect on uterine vascular resistance in vivo , but greater NO‐independent mechanisms mediating the uterine vasodilator response to methacholine ex vivo . These findings highlight that fetal sex may influence maternal cardiovascular function during obese pregnancy.